15 studies found for:    "Nephrogenic Systemic Fibrosis"
Show Display Options
Rank Status Study
1 Unknown  Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Conditions: Nephrogenic Fibrosing Dermopathy;   Nephrogenic Systemic Fibrosis
Intervention: Procedure: Plasmapheresis
2 Enrolling by invitation Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
Conditions: Nephrogenic Systemic Fibrosis;   Nephrogenic Fibrosing Dermopathy
Intervention:
3 Completed Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
Condition: Nephrogenic Systemic Fibrosis
Intervention:
4 Completed Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec
Condition: Nephrogenic Systemic Fibrosis
Intervention: Drug: Imatinib mesylate (Glivec)
5 Suspended Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
Conditions: Nephrogenic Systemic Fibrosis;   Renal Insufficiency
Intervention:
6 Unknown  Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis
Condition: Nephrogenic Systemic Fibrosis
Intervention: Drug: Imatinib mesylate
7 Enrolling by invitation Nephrogenic Systemic Fibrosis With Gadollinum
Conditions: Nephrogenic Systemic Fibrosis;   Renal Failure
Intervention: Drug: gadollinum
8 Completed Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
Condition: Nephrogenic Systemic Fibrosis
Intervention: Drug: Ablavar
9 Completed Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)
Condition: Renal Insufficiency
Intervention:
10 Completed Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Conditions: Fibrosis;   Kidney Failure;   Renal Insufficiency
Intervention: Procedure: Lab sample drawn for serum chemistry at baseline visit
11 Completed Primovist / Eovist in Renally Impaired Patients
Condition: Contrast Media
Intervention: Drug: Primovist (Gadoxetic acid disodium, BAY86-4873)
12 Active, not recruiting Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease
Condition: Renal Insufficiency
Intervention:
13 Active, not recruiting Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease
Condition: Renal Insufficiency
Intervention:
14 Active, not recruiting Safety of Gadovist in Renally Impaired Patients
Conditions: Fibrosis;   Renal Impairment
Intervention: Drug: Gadobutrol (Gadovist, BAY86-4875)
15 Completed
Has Results
Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
Conditions: Chronic Kidney Disease;   Renal Insufficiency
Intervention: Drug: Omniscan

Indicates status has not been verified in more than two years